Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ran N. Tao
A Nanobody Activation Immunotherapeutic That Selectively Destroys HER2-Positive Breast Cancer Cells
ChemBioChem
Organic Chemistry
Biochemistry
Molecular Medicine
Molecular Biology
Related publications
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Selective Cytotoxicity to HER2 Positive Breast Cancer Cells by Saporin-Loaded Nanobody-Targeted Polymeric Nanoparticles in Combination With Photochemical Internalization
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Modulating Cancer Stemness Provides Luminal a Breast Cancer Cells With HER2 Positive-Like Features
Journal of Cancer
Oncology
Targeted Therapy for HER2 Positive Breast Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
Cancer Research
Cancer Research
Oncology
Effects of Herceptin on Circulating Tumor Cells in HER2 Positive Early Breast Cancer
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Optimal Treatment of Early Stage HER2-positive Breast Cancer
Cancer
Cancer Research
Oncology
Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
Scientific Reports
Multidisciplinary
Current Neoadjuvant Treatment Options for HER2 Positive Breast Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
